How to Buy Aquestive Therapeutics Stock
Aquestive Therapeutics Inc
Aquestive Therapeutics, Inc. , a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally.
Aquestive Therapeutics stock last closed at $3.93, up 0.77% from the previous day, and has increased 207.03% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 2.16 percentage points. Aquestive Therapeutics stock is currently +230.25% from its 52-week low of $1.19, and -36.92% from its 52-week high of $6.23.
At the moment, there are 73.3M AQST shares outstanding. The market value of AQST is $288.07M. In the last 24 hours, 1.91M AQST shares were traded.
How to Buy Aquestive Therapeutics Stock
Wondering how to invest in Aquestive Therapeutics stock? Here's how.
- Choose where to buy Aquestive Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you choose where to buy Aquestive Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Choose your method of payment and add your details.
- Analyze Aquestive Therapeutics stock: The Aquestive Therapeutics ticker symbol is AQST. Is Aquestive Therapeutics stock a good investment? Should you buy shares of AQST? How do AQST's underlying business fundamentals look? Do top analysts think Aquestive Therapeutics is a good buy? Why has AQST's stock price moved recently? (Hint: Our stock research website can help you evaluate if AQST is a good stock to buy).
- Place your AQST purchase: Decide if you will purchase AQST shares at the current market price or use a limit order to purchase AQST stock at a particular price.
- Watch your AQST position: Create a watchlist to track your new investment in Aquestive Therapeutics shares.
Step 1: Choose where to buy Aquestive Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy AQST shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal details so you are able to buy AQST today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new brokerage account.
- Send your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on the best beginner stock app, you can securely and quickly fund your account:
Check out the tutorial below to see the process of depositing funds into your brokerage account.
Step 4: Analyze Aquestive Therapeutics stock
After you have chosen the best place to buy Aquestive Therapeutics stock, it's crucial to evaluate their stock prior to investing, so you actually understand the risk as well as the upside.
Aquestive Therapeutics Metrics
Aquestive Therapeutics Fundamentals
WallStreetZen was created to help average investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on AQST's stock page.
What is the fair value of AQST stock?
Analysts use many financial metrics, analyses, models, and charts to gauge AQST's true value.
You can do more valuation analysis on AQST's stock here.
AQST Financial Health Summary
Passed Financial Due Diligence Checks:
- AQST has cash burn of 7375000. It has enough cash and short-term investments to cover this for at least one year.
- AQST profit margin has gone up from -114.1% to -15.6% in the past year.
- AQST has $23.87M in cash and short term investments. This is sufficient to cover its annual cash burn of $7.38M.
- There are more short-term assets than short-term liabilities on the AQST balance sheet.
Failed Financial Due Diligence Checks:
- AQST debt to equity ratio of -1.54 is negative.
- There are more long-term liabilities than short-term assets on the AQST balance sheet.
- Total AQST debt is still negative.
Do Wall Street analysts think it's a good time to buy AQST stock
Out of 6 Wall Street analysts who monitor AQST, the consensus analyst rating on AQST is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest AQST Analyst Recommendations
Thomas Flaten, a bottom 2% analyst from Lake Street maintains AQST with a strong buy rating and raises their AQST price target from $3.00 to $8.00, on Mar 7, 2024.
You can dive deeper into what analysts are projecting on the Aquestive Therapeutics stock forecast page.
AQST Trading Indicators
AQST Earnings
Last year, AQST revenue was $50.58M. During the past five year, AQST's revenue has increased by -5.59% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.67%.
You can research AQST's earnings and revenue performance here.
Are AQST insiders buying or selling the stock?
In the last year, insiders at AQST have sold more shares than they have bought.
Alexander Mark Schobel, Chief InnovationTech Officer of AQST, was the latest AQST insider to sell. They sold $300,000.00 worth of AQST stock on Mar 15, 2024.
Research more about who owns AQST stock here.
Does AQST stock generate passive income?
No, Aquestive Therapeutics doesn't provide an income stream by paying out dividends.
AQST Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your AQST purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount, use a limit order.
Hit the Open button and eToro will place the order.
If you want more assistance investing in stocks on eToro, click the how to video below:
Step 6: Watch your AQST position
Now that you own some AQST shares, you'll want to stay up-to-date on your new investment.
Start a watchlist to see the latest developments about your AQST stock.
AQST Feed
How to Buy Stock in Aquestive Therapeutics
To reiterate, here are the 6 steps to buy Aquestive Therapeutics stock:
- Choose where to buy Aquestive Therapeutics stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Aquestive Therapeutics stock
- Place your AQST purchase
- Watch your AQST position
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Aquestive Therapeutics, get started below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.